Category: Leukemia

Optimizing HSCT in Blood Cancers

Lori Muffly MD, MS, Stanford Medicine, Stanford, CA

Driving Progress in AML

David Sallman, MD, Moffitt Cancer Center, Tampa, FL

What’s New and What’s Next in CLL

Brad Kahl, MD, Siteman Cancer Center, St. Louis MO

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Hairy Cell Leukemia: Strategies for Improved Patient Outcomes

Paul J. Hampel, MD, Mayo Clinic, Rochester, MN

Managing CML: What HCPs Need to Know

Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Scroll to Top